[The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects; D001782:Blood Donors; D002648:Child; D004305:Dose-Response Relationship, Drug; D005169:Factor VIII / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis / Q000627:therapeutic use*; D005260:Female; D005340:Fibrinogen / Q000008:administration & dosage / Q000627:therapeutic use; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D006470:Hemorrhage / Q000517:prevention & control; D006487:Hemostasis; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D014947:Wounds and Injuries / Q000150:complications
D005169:Factor VIII; D005340:Fibrinogen
Die Behandlung der Hämophilie A mit der neuen antihämophilen Fraktion "AHF SRK (Human)". Vergleich mit dem Antihämophilen Globulin, AHG, SRK